Compare Edwards Lifesciences Corporation Common Stock (EW) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Snap Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.21 (market cap $48.56B), while Snap Inc trades at $6.24 (market cap $9.83B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 4.9× Snap Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Snap Inc nearer its low. Which is the better fit depends on your goals.
| EW | SNAP | |
|---|---|---|
Market Cap | $48.56B | $9.83B |
Volume | 6,520,488 | 28,532,342 |
Sector | Health | Media |
52-Week High | $95.18 | $9.09 |
52-Week Low | $72.65 | $3.93 |
Enterprise Value | $45.01B | $11.39B |
Typical Hold Time | — | 68 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Snap Inc. (SNAP) trades at $5.865, up 0.95% with bullish technical signals and improving fundamentals. The stock shows positive momentum with three consecutive earnings beats despite negative profitability metrics. Recent news highlights Snap's expansion into enterprise AI services through partnerships with NVIDIA and Salesforce for its SPECS augmented reality glasses, driving investor optimism about future revenue streams.
While Snap demonstrates revenue growth and narrowing losses, the stock faces significant risks from continued negative net income margins and high valuation multiples. Analyst consensus leans cautious with 55% hold ratings, though the $7.78 price target suggests 33% upside potential. The company's pivot to enterprise AI represents both opportunity and execution risk in a competitive market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
